Flow cytometry, in particular, is projected to lead the market in 2025, accounting for 38.4% of the total instrument and ...

Innovative and cutting-edge technology transforms functional live-cell analysis by enabling precise, flexible, and scalable end-to-end immuno-oncology, antibody, and cell therapy discovery.

Not all patients respond well to chimeric antigen receptor (CAR) T cell therapies, which reprogram a patient’s own immune cells to recognize and attack cancer. A way to optimize these treatments is to ...

Regulatory T cells, which prevent the immune system from attacking the body, were the subject of this year’s Physiology or ...

In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing immune cells that could make “off-the-shelf” cancer medications more potent ...

New research maps how bone marrow changes in acute myeloid leukemia disrupt neutrophil development and boost the risk for ...